LUT014 is being explored for its potential in dermatology, particularly in the treatment of skin conditions. It has shown promise in addressing side effects associated with certain cancer therapies, such as EGFR inhibitor-induced skin rashes. By targeting specific pathways involved in skin inflammation and repair, LUT014 may help alleviate these adverse effects, improving patient comfort and adherence to cancer treatment regimens. Its application is currently under investigation in clinical trials to evaluate efficacy and safety in this context.